Kestra Medical Technologies (KMTS) Invested Capital (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Invested Capital data on file, last reported at $288.0 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $288.0 million, up 234.48% year-over-year; the trailing twelve-month figure through Jan 2026 was $288.0 million (up 234.48% YoY), and the FY2025 annual result was $246.5 million, up 247.75% from the prior year.
• Invested Capital improved to $288.0 million in Q1 2026 per KMTS's latest filing, from $164.1 million in the prior quarter.
• Over five years, Invested Capital peaked at $288.0 million in Q1 2026 and troughed at -$236.5 million in Q4 2024.
• A 3-year average of -$10.8 million and a median of -$166.8 million in 2024 frame the typical range for Invested Capital.
• On a YoY basis, Invested Capital climbed as much as 247.75% in 2025 and fell as far as 14.38% in 2025.
• A 3-year view of Invested Capital shows it stood at -$236.5 million in 2024, then jumped by 169.37% to $164.1 million in 2025, then jumped by 75.52% to $288.0 million in 2026.
• Business Quant data shows KMTS's Invested Capital at $288.0 million in Q1 2026, $164.1 million in Q4 2025, and $225.6 million in Q3 2025.